Skip to content

Medical-device intelligence

OVB: Hydrogel Spacer

FDA product code OVB: Hydrogel Spacer. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
OVB
FDA device name
Hydrogel Spacer
Device class
2
Regulation number
892.5725
Medical specialty
Radiology
Review panel
RA

FDA definition

The perirectal spacer is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of the perirectal spacer to reduce the radiation dose delivered to the anterior rectum. The perirectal spacer is composed of biodegradable material and maintains space for the entire course of prostate radiotherapy treatment and is completely absorbed by the patient’s body over time.
Explore radiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

7 clearance records and 2 recall records in the covered releases, across 4 source company names and 1 product codes. Dated history runs from Jun 25, 2018 to Sep 11, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202610
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202610
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
OVB · Hydrogel Spacer72

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

9 matching records
Device / recordCompany in FDA recordSourceSource date
SpaceOAR Flex™ SystemK262151 · OVBBoston Scientific Corporation510(k)Sep 11, 2026FDA decision date
SpaceOAR Vue System (SV-2101)K260119 · OVBBoston Scientific Corporation510(k)Feb 10, 2026FDA decision date
BioProtect Balloon Implant™ SystemK222972 · OVBBioprotect, Ltd.510(k)Aug 25, 2023FDA decision date
Barrigel Injectable GelK220641 · OVBPalette Life Sciences510(k)May 26, 2022FDA decision date
SpaceOAR System, UPN SO-1010, SO-2101, SO-3101, and SO-4101. Used to temporarily position the anterior rectal wall away from the prostate during…Z-1002-2022 · OVBBoston Scientific CorporationRecallApr 25, 2022FDA record creation date
SpaceOAR Vue System, UPN SV-1010 and SV-2101. Used to temporarily position the anterior rectal wall away from the prostate during radiotherapy f…Z-1003-2022 · OVBBoston Scientific CorporationRecallApr 25, 2022FDA record creation date
SpaceOAR SystemK202224 · OVBBoston Scientific Corporation510(k)Aug 28, 2020FDA decision date
SpaceOAR Vue HydrogelK182971 · OVBAugmenix, Inc.510(k)Jul 19, 2019FDA decision date
SpaceOAR SystemK181465 · OVBAugmenix, Inc.510(k)Jun 25, 2018FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗